⌘K

Home/Filings/4/0000950170-25-018993

4//SEC Filing

Gallagher Neil 4

Accession 0000950170-25-018993

CIK 0001395937other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:13 PM ET

Size

4.7 KB

Accession

0000950170-25-018993

Insider Transaction Report

Form 4

Period: 2025-02-10

Syndax Pharmaceuticals IncSNDX

President, Head of R&D

Transactions

Sale
Common Stock
2025-02-10$15.50/sh−4,618$71,597→ 85,095 total

Footnotes (1)

[F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001972849

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:13 PM ET
Size: 4.7 KB

View on SEC.gov